Dr. Hessam Aazami, MD

Dr. Aazami practices at 101 Family Medical Group,A Professional Corp in Canoga Park, California.

Dr. Aazami's NPI, 1144299173, was assigned on March 14, 2006. Dr. Aazami holds California license A85704.

Dr. Aazami's primary practice is 101 Family Medical Group,A Professional Corp, at 22030 W Sherman Way, Canoga Park, CA 91303 in Los Angeles County. The practice phone is (818) 312-9101.

Dr. Aazami's primary practice is 101 Family Medical Group,A Professional Corp in Canoga Park, California. Dr. Aazami is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is 101 Family Medical Group. Dmand AI also links Dr. Aazami to 2 more home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aazami practices, 4 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Aazami's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Aazami is licensed in California.

CMS data shows 2,169 Medicare services from Dr. Aazami across 15 procedure codes in 2024, for 351 Medicare patients. Medicare paid $128,648 for them. Every service was in an office.

CMS counts 351 Medicare patients who saw Dr. Aazami in 2026. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 92% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aazami's median patient age at 60, with 56% women.

In 2026, Dr. Aazami wrote 5,830 Medicare Part D claims for 412 patients. 80% of them were for generic drugs. CMS names the drug for 5,342 of them, across 99 drugs with 11 or more claims each, at $684,390 in total drug cost. In 2023, CMS named 5,177 claims across 96 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Aazami for performance year 2026, reported individually. Dr. Aazami accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aazami as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Aazami, published from 2017 to 2022. 2022 was the busiest year, with 2. The most frequent topics are COVID-19 and Double-Blind Method. Dr. Aazami has published most often in N Engl J Med. Dr. Aazami's most frequent co-authors are Gerard Frantz Acloque, MD, Ana M. Acosta, MD and Shazia Ali, MD.

Dmand AI links Dr. Aazami to 14 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include COVID-19, Pneumonia, Viral and Obesity. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Aazami that name 9 trials.

CMS Open Payments shows 786 general payments to Dr. Aazami from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Amgen Inc. paid the most, $6,145. It also lists 43 research payments totaling $630,701 from 2017 to 2025, naming 9 clinical trials.